Pages that link to "Q36313476"
Jump to navigation
Jump to search
The following pages link to Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever (Q36313476):
Displaying 36 items.
- HPV vaccine: Current status and future directions (Q27026524) (← links)
- Vaccines: the Fourth Century (Q27490454) (← links)
- Current Status of Human Papillomavirus Vaccines (Q28289555) (← links)
- Papillomavirus prophylactic vaccines: established successes, new approaches (Q33614425) (← links)
- Social values and scientific evidence: the case of the HPV vaccines (Q33890189) (← links)
- Reducing HPV-associated cancer globally. (Q34244580) (← links)
- HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future (Q34335370) (← links)
- Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice (Q34532843) (← links)
- Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India (Q35112350) (← links)
- HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig model (Q35498376) (← links)
- A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection (Q35599310) (← links)
- Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor (Q35798992) (← links)
- Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania (Q35886738) (← links)
- Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery (Q36145803) (← links)
- A review of clinical trials of human papillomavirus prophylactic vaccines (Q36259403) (← links)
- A Live Vector Expressing HPV16 L1 Generates an Adjuvant-Induced Antibody Response In-vivo (Q36529355) (← links)
- Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer (Q36593956) (← links)
- Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells. (Q36643691) (← links)
- Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8⁺ T Lymphocytes in the Female Reproductive Tract. (Q36735275) (← links)
- Human papillomavirus infection and the primary and secondary prevention of cervical cancer. (Q37271947) (← links)
- New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention (Q37274559) (← links)
- Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines. (Q37291438) (← links)
- Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization (Q37391175) (← links)
- Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer (Q37488845) (← links)
- Perspectives for the development of human papillomavirus vaccines and immunotherapy (Q37658876) (← links)
- Vaccines to prevent infections by oncoviruses (Q37737321) (← links)
- Therapeutic live vaccines as a potential anticancer strategy. (Q38011653) (← links)
- Next generation prophylactic human papillomavirus vaccines (Q38460209) (← links)
- Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer. (Q38961435) (← links)
- Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin (Q39860799) (← links)
- HPV vaccines: Global perspectives (Q40265515) (← links)
- Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles (Q45384700) (← links)
- Conversion of RpoS- Attenuated Salmonella enterica Serovar Typhi Vaccine Strains to RpoS+ Improves Their Resistance to Host Defense Barriers. (Q53704376) (← links)
- Emerging human papillomavirus vaccines (Q56967486) (← links)
- Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus (Q59329445) (← links)
- Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 & 18): Regulatory toxicology studies in mice, rats and rabbits - An innovative approach (Q104694220) (← links)